Carolyn Y. Ho

18.7k total citations · 3 hit papers
135 papers, 7.1k citations indexed

About

Carolyn Y. Ho is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Carolyn Y. Ho has authored 135 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Cardiology and Cardiovascular Medicine, 43 papers in Molecular Biology and 25 papers in Epidemiology. Recurrent topics in Carolyn Y. Ho's work include Cardiomyopathy and Myosin Studies (108 papers), Cardiovascular Function and Risk Factors (46 papers) and Cardiovascular Effects of Exercise (43 papers). Carolyn Y. Ho is often cited by papers focused on Cardiomyopathy and Myosin Studies (108 papers), Cardiovascular Function and Risk Factors (46 papers) and Cardiovascular Effects of Exercise (43 papers). Carolyn Y. Ho collaborates with scholars based in United States, Italy and United Kingdom. Carolyn Y. Ho's co-authors include Christine E. Seidman, Allison L. Cirino, Scott D. Solomon, Neal K. Lakdawala, Steven D. Colan, Iacopo Olivotto, Jonathan G. Seidman, Sharlene M. Day, Francesca Girolami and Daniel Jacoby and has published in prestigious journals such as New England Journal of Medicine, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Carolyn Y. Ho

128 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy

2010 484 citations Carolyn Y. Ho, Begoña López et al. New England Journal of Medicine profile →
Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy

2018 456 citations Carolyn Y. Ho, Sharlene M. Day et al. Circulation profile →
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

2021 127 citations Perry Elliott, Carolyn Y. Ho et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carolyn Y. Ho United States	50	5.9k	2.1k	1.0k	651	544	135	7.1k
Jens Mogensen Denmark	29	5.8k 1.0×	1.8k 0.8×	724 0.7×	339 0.5×	602 1.1×	67	6.6k
Benjamin Meder Germany	44	2.3k 0.4×	4.1k 1.9×	365 0.4×	370 0.6×	399 0.7×	198	6.5k
Wolfgang Rottbauer Germany	39	2.9k 0.5×	2.4k 1.1×	1.0k 1.0×	772 1.2×	821 1.5×	251	5.7k
J. Peter van Tintelen Netherlands	47	5.8k 1.0×	2.5k 1.1×	191 0.2×	106 0.2×	519 1.0×	196	7.2k
Craig T. Basson United States	41	2.7k 0.5×	4.4k 2.1×	1.9k 1.8×	211 0.3×	1.5k 2.8×	87	7.9k
Yasuhiko Hayashi Japan	26	1.1k 0.2×	583 0.3×	340 0.3×	947 1.5×	1.6k 3.0×	183	3.5k
Anoek Zomer Netherlands	22	940 0.2×	1.7k 0.8×	908 0.9×	197 0.3×	835 1.5×	36	3.7k
Kenji Nakamura Japan	35	465 0.1×	1.4k 0.6×	787 0.8×	261 0.4×	1.5k 2.8×	232	5.0k
Patricia K. Nguyen United States	28	878 0.1×	1.1k 0.5×	120 0.1×	642 1.0×	761 1.4×	83	3.1k
Eric Larsen United States	30	735 0.1×	1.1k 0.5×	103 0.1×	199 0.3×	338 0.6×	100	4.3k

Countries citing papers authored by Carolyn Y. Ho

Since Specialization

Citations

This map shows the geographic impact of Carolyn Y. Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carolyn Y. Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carolyn Y. Ho more than expected).

Fields of papers citing papers by Carolyn Y. Ho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carolyn Y. Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carolyn Y. Ho. The network helps show where Carolyn Y. Ho may publish in the future.

Co-authorship network of co-authors of Carolyn Y. Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Carolyn Y. Ho. A scholar is included among the top collaborators of Carolyn Y. Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carolyn Y. Ho. Carolyn Y. Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Benz, Dominik C., Olivier Clerc, Alexandra Taylor, et al.. (2025). Echocardiographic Characterization of Myocardial Stiffness in Healthy Volunteers, Cardiac Amyloidosis, and Hypertrophic Cardiomyopathy: A Case-Control Study Using Multimodality Imaging. Circulation Cardiovascular Imaging. 18(3). e017475–e017475.

Kaski, Juan Pablo, Paul F. Kantor, Stephanie J. Nakano, et al.. (2025). Efficacy and Safety of Aficamten in Children and Adolescents With Obstructive Hypertrophic Cardiomyopathy: Study Design and Rationale of CEDAR-HCM. Circulation Heart Failure. 19(2). e013418–e013418.

Atwell, S., Timothy C. Cheung, Elaine M. Conner, et al.. (2025). Quantitative detection of the HVEM-BTLA checkpoint receptor cis-complex in human lymphocytes. The Journal of Immunology. 214(3). 565–572.

Sucharov, Carmen C., et al.. (2023). Circulating MicroRNAs Identify Early Phenotypic Changes in Sarcomeric Hypertrophic Cardiomyopathy. Circulation Heart Failure. 16(6). e010291–e010291. 8 indexed citations

Cheung, Timothy C., S. Atwell, Lisa M. Bafetti, et al.. (2023). Epitope topography of agonist antibodies to the checkpoint inhibitory receptor BTLA. Structure. 31(8). 958–967.e3. 6 indexed citations

Marston, Nicholas, Larry Han, Iacopo Olivotto, et al.. (2021). Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy. European Heart Journal. 42(20). 1988–1996. 67 indexed citations

Hegde, Sheila M., Steven J. Lester, Scott D. Solomon, et al.. (2021). Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy. Journal of the American College of Cardiology. 78(25). 2518–2532. 102 indexed citations

Repetti, Giuliana G., Yuri Kim, Alexandre C. Pereira, et al.. (2021). Discordant clinical features of identical hypertrophic cardiomyopathy twins. Proceedings of the National Academy of Sciences. 118(10). 27 indexed citations

Canepa, Marco, Carlo Fumagalli, Giacomo Tini, et al.. (2020). Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy. Circulation Heart Failure. 13(9). e007230–e007230. 49 indexed citations

10.

Olivotto, Iacopo, Carolyn Y. Ho, Daniel Jacoby, et al.. (2018). Abstract 16466: EXPLORER-HCM: Phase 3 Randomized, Multi-Center, Double-Blind, Placebo-Controlled Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy. Circulation. 2 indexed citations

11.

Williams, Lynne, Carolyn Y. Ho, Yoram Agmon, et al.. (2018). Multilayer Myocardial Mechanics in Genotype-Positive Left Ventricular Hypertrophy-Negative Patients With Hypertrophic Cardiomyopathy. The American Journal of Cardiology. 122(10). 1754–1760. 18 indexed citations

12.

Homburger, Julian R., Eric M. Green, Colleen Caleshu, et al.. (2016). Multidimensional structure-function relationships in human β-cardiac myosin from population-scale genetic variation. Proceedings of the National Academy of Sciences. 113(24). 6701–6706. 80 indexed citations

13.

Velden, Jolanda van der, Carolyn Y. Ho, Jil C. Tardiff, et al.. (2015). Research priorities in sarcomeric cardiomyopathies. Cardiovascular Research. 105(4). 449–456. 35 indexed citations

14.

Ho, Carolyn Y.. (2015). The Islamic State (Daesh) Healthcare Paradox: A Caliphate in Crisis. Journal of Global Health. 7 indexed citations

15.

Ho, Carolyn Y.. (2015). Community reintegration of patients with neurological disorders post discharge from the Kachere Rehabilitation Centre, Malawi. Journal of Global Health. 2 indexed citations

16.

Ho, Carolyn Y., et al.. (2014). Dural metastasis of nasopharyngeal carcinoma: rare, but worth considering. Singapore Medical Journal. 55(5). e82–e84. 5 indexed citations

17.

Lewis, Steven M., Xiufeng Wu, Anna Pustilnik, et al.. (2014). Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface. Nature Biotechnology. 32(2). 191–198. 196 indexed citations

18.

Ho, Carolyn Y., Begoña López, Otávio R. Coelho‐Filho, et al.. (2010). Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy. New England Journal of Medicine. 363(6). 552–563. 484 indexed citations breakdown →

19.

Zimmerman, Rebekah, Stephanie Cox, Neal K. Lakdawala, et al.. (2010). A novel custom resequencing array for dilated cardiomyopathy. Genetics in Medicine. 12(5). 268–278. 64 indexed citations

20.

Lakdawala, Neal K., Jens Jakob Thune, Allison L. Cirino, et al.. (2009). Abstract 1892: Electrocardiographic Manifestations of Sarcomere Mutations in Hypertrophic Cardiomyopathy: Incremental Value in the Prediction of Genetic Risk. Circulation. 120. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact